189 related articles for article (PubMed ID: 11717414)
1. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia.
Notterpek L; Roux KJ; Amici SA; Yazdanpour A; Rahner C; Fletcher BS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14404-9. PubMed ID: 11717414
[TBL] [Abstract][Full Text] [Related]
2. The temporospatial expression of peripheral myelin protein 22 at the developing blood-nerve and blood-brain barriers.
Roux KJ; Amici SA; Notterpek L
J Comp Neurol; 2004 Jul; 474(4):578-88. PubMed ID: 15174074
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
4. Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom.
Langbein L; Grund C; Kuhn C; Praetzel S; Kartenbeck J; Brandner JM; Moll I; Franke WW
Eur J Cell Biol; 2002 Aug; 81(8):419-35. PubMed ID: 12234014
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study.
Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T
J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245
[TBL] [Abstract][Full Text] [Related]
6. Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination.
Notterpek L; Snipes GJ; Shooter EM
Glia; 1999 Feb; 25(4):358-69. PubMed ID: 10028918
[TBL] [Abstract][Full Text] [Related]
7. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
8. Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development.
Baechner D; Liehr T; Hameister H; Altenberger H; Grehl H; Suter U; Rautenstrauss B
J Neurosci Res; 1995 Dec; 42(6):733-41. PubMed ID: 8847735
[TBL] [Abstract][Full Text] [Related]
9. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes.
Brandner JM; Kief S; Grund C; Rendl M; Houdek P; Kuhn C; Tschachler E; Franke WW; Moll I
Eur J Cell Biol; 2002 May; 81(5):253-63. PubMed ID: 12067061
[TBL] [Abstract][Full Text] [Related]
10. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
[TBL] [Abstract][Full Text] [Related]
11. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.
Amici SA; Dunn WA; Murphy AJ; Adams NC; Gale NW; Valenzuela DM; Yancopoulos GD; Notterpek L
J Neurosci; 2006 Jan; 26(4):1179-89. PubMed ID: 16436605
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair.
Kuhn G; Lie A; Wilms S; Müller HW
Glia; 1993 Aug; 8(4):256-64. PubMed ID: 7691737
[TBL] [Abstract][Full Text] [Related]
13. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
14. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies.
Naef R; Adlkofer K; Lescher B; Suter U
Mol Cell Neurosci; 1997 Jan; 9(1):13-25. PubMed ID: 9204477
[TBL] [Abstract][Full Text] [Related]
15. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice.
Carenini S; Neuberg D; Schachner M; Suter U; Martini R
Glia; 1999 Dec; 28(3):256-64. PubMed ID: 10559784
[TBL] [Abstract][Full Text] [Related]
16. Impairment of tight junctions and glucose transport in endothelial cells of human cerebral cavernous malformations.
Schneider H; Errede M; Ulrich NH; Virgintino D; Frei K; Bertalanffy H
J Neuropathol Exp Neurol; 2011 Jun; 70(6):417-29. PubMed ID: 21572340
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium.
Acharya P; Beckel J; Ruiz WG; Wang E; Rojas R; Birder L; Apodaca G
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F305-18. PubMed ID: 15068973
[TBL] [Abstract][Full Text] [Related]
18. Alterations in tight junction molecules of uterine epithelial cells during early pregnancy in the rat.
Orchard MD; Murphy CR
Acta Histochem; 2002; 104(2):149-55. PubMed ID: 12086335
[TBL] [Abstract][Full Text] [Related]
19. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
Li J; Ghandour K; Radovanovic D; Shy RR; Krajewski KM; Shy ME; Nicholson GA
Arch Neurol; 2007 Jul; 64(7):974-8. PubMed ID: 17620487
[TBL] [Abstract][Full Text] [Related]
20. Mammalian occludin in epithelial cells: its expression and subcellular distribution.
Saitou M; Ando-Akatsuka Y; Itoh M; Furuse M; Inazawa J; Fujimoto K; Tsukita S
Eur J Cell Biol; 1997 Jul; 73(3):222-31. PubMed ID: 9243183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
